Halozyme Therapeutics, Inc. (HALO)
128.51
+0.50
(+0.39%)
USD |
NASDAQ |
Oct 27, 16:00
128.50
-0.01
(-0.01%)
After-Hours: 20:00
Halozyme Therapeutics Total Return Level : 128.01 for Oct. 26, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 26, 2026 | 128.01 |
| October 23, 2026 | 125.63 |
| October 22, 2026 | 124.54 |
| October 21, 2026 | 124.83 |
| October 20, 2026 | 124.37 |
| October 19, 2026 | 122.50 |
| October 16, 2026 | 121.84 |
| October 15, 2026 | 121.51 |
| October 14, 2026 | 116.82 |
| October 13, 2026 | 109.62 |
| October 12, 2026 | 111.08 |
| October 09, 2026 | 110.42 |
| October 08, 2026 | 109.84 |
| October 07, 2026 | 110.79 |
| October 06, 2026 | 109.72 |
| October 05, 2026 | 108.31 |
| October 02, 2026 | 109.86 |
| October 01, 2026 | 106.94 |
| September 30, 2026 | 110.40 |
| September 29, 2026 | 111.56 |
| September 28, 2026 | 112.89 |
| September 25, 2026 | 113.90 |
| September 24, 2026 | 115.22 |
| September 23, 2026 | 112.44 |
| September 22, 2026 | 115.13 |
| Date | Value |
|---|---|
| September 21, 2026 | 111.45 |
| September 18, 2026 | 112.45 |
| September 17, 2026 | 109.68 |
| September 16, 2026 | 108.44 |
| September 15, 2026 | 106.25 |
| September 14, 2026 | 107.94 |
| September 11, 2026 | 107.20 |
| September 10, 2026 | 107.00 |
| September 09, 2026 | 107.39 |
| September 08, 2026 | 108.31 |
| September 04, 2026 | 110.19 |
| September 03, 2026 | 110.76 |
| September 02, 2026 | 109.66 |
| September 01, 2026 | 107.72 |
| August 31, 2026 | 106.49 |
| August 28, 2026 | 105.35 |
| August 27, 2026 | 106.92 |
| August 26, 2026 | 107.06 |
| August 25, 2026 | 109.32 |
| August 24, 2026 | 108.64 |
| August 21, 2026 | 108.17 |
| August 20, 2026 | 106.12 |
| August 19, 2026 | 107.62 |
| August 18, 2026 | 104.89 |
| August 17, 2026 | 103.00 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| AVITA Medical, Inc. | 15.18 |
| Iovance Biotherapeutics, Inc. | 13.78 |
| Merck & Co., Inc. | 434.82 |
| Agenus, Inc. | 6.16 |
| Amgen, Inc. | 665.80 |